Posts by: Patricia Inacio, PhD

Pulmonary rehabilitation programs can improve exercise capacity and health-related quality of life in patients with interstitial lung diseases (ILDs), including those with pulmonary fibrosis, a study shows. These findings support ... Read more

October 17, 2017October 17, 2017

Opdivo, Alone or Combined with Yervoy, Extends Lung Cancer Patients’ Survival, Phase 1/2 Trial Shows

Lung Cancer, News

Opdivo (nivolumab) has shown promise as a treatment for recurring small lung cancer patients who have a lot of genetic errors in their tumors, according to a Phase 1/2 clinical trial. ... Read more

October 3, 2017October 3, 2017

Baseball Legend, Country Singer to Join Renowned Scientists at Pulmonary Fibrosis Summit

Idiopathic Pulmonary Fibrosis, News

A New York Yankees legend and a country music singer will join renowned scientists in speaking at the Pulmonary Fibrosis Foundation’s international PFF Summit 2017 in Nashville, Nov. 9-11. Top physicians and researchers ... Read more

August 24, 2017August 25, 2017

Ethris, AstraZeneca and MedImmune to Collaborate on Developing Respiratory Disease Therapies

Asthma, COPD, Idiopathic Pulmonary Fibrosis, News

Ethris has entered into a five-year research partnership with AstraZeneca and its subsidiary MedImmune to develop mRNA-based therapies for lung diseases. The partnership will use Ethris’ proprietary SNIM®RNA technology. The nucleic acid ... Read more

August 18, 2017August 18, 2017

Vaccination Against Lung Pathogens Vital for People with Lung Disease, American Lung Association Reminds

Asthma, COPD, News, Pneumonia

August is National Immunization Awareness Month, and the American Lung Association is reminding adults with serious lung diseases that the Centers for Disease Control and Prevention (CDC) recommends vaccination against common ... Read more

August 2, 2017August 2, 2017

NYC Survivors of 9/11 Attack at Higher Risk for Chronic Heart, Lung Diseases, Study Shows

News

Nearly 16 years after terrorists destroyed New York’s World Trade Center, people who were exposed to high concentrations of hazardous materials and dust clouds still face significantly higher rates of chronic ... Read more

June 22, 2017June 22, 2017

Supplemental Oxygen Improves Exercise Endurance in IPF Patients, Study Finds

Idiopathic Pulmonary Fibrosis, News

Supplemental oxygen enhances exercise endurance and reduces breathing difficulties in patients with idiopathic pulmonary fibrosis (IPF), an Australian study shows. The study, “Greater endurance capacity and improved dyspnoea with acute ... Read more

October 24, 2016October 24, 2016

FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) approved Genentech’s Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC). The drug is specifically indicated for NSCLC patients whose ... Read more

October 18, 2016October 18, 2016

Tecentriq for Lung Cancer Outperforms Conventional Chemotherapy, Increases Survival in Phase 3 Study

News

Genentech recently announced positive results from the pivotal Phase 3 OAK study (NCT02008227) demonstrating that its cancer immunotherapy Tecentriq (atezolizumab) is more effective than the chemotherapy Taxotere for increasing patients’ median overall survival. The findings were presented at ... Read more

September 27, 2016September 27, 2016

UCLA Researchers Develop 3D ‘Lung Organoids’ as New Tool to Study Lung Diseases

Idiopathic Pulmonary Fibrosis, News

By converting adult lung cells to stem cells, a team of UCLA researchers developed mini-lungs in a culture dish, called lung organoids. This 3D lung tissue can be used to study ... Read more